Evidence map›Paper›PMID 41639320›Full record

ArticleActa pharmacologica Sinica2026

VsNsbench: evaluating AlphaFold3-embed induced-fit mechanism for enhanced virtual screening.

Shu-Kai Gu, Chao Shen, Yu-Wei Yang, Si-Long Zhai, Jing Li, Ya-Nan Tian, Xu-Jun Zhang, Hong-Yan Du, Zhen-Xing Wu, Xiao-Rui Wang and 7 more

Abstract read
In one paragraph

Article in Acta pharmacologica Sinica, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Shu-Kai GuFaculty of Applied Science, Macao Polytechnic University, Macao, China.
Chao ShenDepartment of Clinical Pharmacy, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, 310003, China.
Yu-Wei YangFaculty of Applied Science, Macao Polytechnic University, Macao, China.
Si-Long ZhaiFaculty of Applied Science, Macao Polytechnic University, Macao, China.
Jing LiFaculty of Applied Science, Macao Polytechnic University, Macao, China.
Ya-Nan TianFaculty of Applied Science, Macao Polytechnic University, Macao, China.
Xu-Jun ZhangCollege of Pharmaceutical Sciences, Zhejiang University, Hangzhou, 310058, China.
Hong-Yan DuCollege of Pharmaceutical Sciences, Zhejiang University, Hangzhou, 310058, China.
Zhen-Xing WuCollege of Pharmaceutical Sciences, Zhejiang University, Hangzhou, 310058, China.
Xiao-Rui WangCollege of Pharmaceutical Sciences, Zhejiang University, Hangzhou, 310058, China.
Jing-Xuan GeCollege of Pharmaceutical Sciences, Zhejiang University, Hangzhou, 310058, China.
Hui-Feng ZhaoCollege of Pharmaceutical Sciences, Zhejiang University, Hangzhou, 310058, China.
Yuan-Sheng HuangCollege of Pharmaceutical Sciences, Zhejiang University, Hangzhou, 310058, China.
Gao-Qi WengVollum Institute, Oregon Health and Science University, Portland, OR, 97239, USA.
Huan-Xiang LiuFaculty of Applied Science, Macao Polytechnic University, Macao, China. hxliu@mpu.edu.mo.
Ting-Jun HouCollege of Pharmaceutical Sciences, Zhejiang University, Hangzhou, 310058, China. tingjunhou@zju.edu.cn.
Yu KangCollege of Pharmaceutical Sciences, Zhejiang University, Hangzhou, 310058, China. yukang@zju.edu.cn.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

While AlphaFold3 (AF3) extends AlphaFold2 (AF2) by predicting holo structures, it remains unclear whether its modeling process captures similar induced-fit mechanisms. In this study, we benchmarked the VS performance of ligand-induced AF3 holo structures on two datasets: a subset of DUD-E and VsNsBench designed to avoid sequence-level information leakage. On both datasets, AF3 holo structures demonstrated substantially improved enriching capability compared to AF3 apo, experimental apo, and AF2 structures. Compared to experimental holo structures, AF3 models demonstrated inferior performance on the DUD-E subset but performed slightly better on VsNsBench. Further analysis revealed that AF3's induced modeling critically depends on the bound ligand's affinity: high-affinity ligands produced conformations enabling excellent enrichment, while low-affinity or random ligands yielded poor performance. Moreover, direct VS using AF3 alone achieved satisfactory performance, but computational efficiency remains a major bottleneck for large-scale applications, even with single-round multiple sequence alignment (MSA) generation. In a DFG-motif kinase case study, AF3 successfully modeled inhibitor-specific conformations with a 75% success rate. These findings demonstrate that AF3 effectively incorporates induced-fit modeling, though improvement is needed, particularly for modeling multi-state conformational ensembles.

Indexed as

Models, MolecularProtein ConformationLigandsLigandsAlphaFold3induced-fit mechanismvirtual screeningVsNsBench

Identifiers

PMID41639320
PMCPMC13197454

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.